文献速递白血病

慢性髓性白血病诊断时及对酪氨酸激酶抑制剂耐药患者显示T细胞耗竭表型

Chronic myeloid leukaemia patients at diagnosis and resistant to tyrosine kinase inhibitor therapy display exhausted T-cell phenotype.
PubMed 文献 · Br J Haematol · 2022-07-08

研究探讨慢性髓性白血病(CML)诊断时及酪氨酸激酶抑制剂(TKI)耐药患者的免疫状态,发现诊断时调节性T细胞及效应调节性T细胞频率增加,T细胞耗竭标志物表达升高,血浆TNF-α和IL-6水平显著升高,提示治疗前存在促炎状态,T细胞耗竭可能继发于白血病相关抗原负荷增加。

要点

  • CML诊断时调节性T细胞及效应调节性T细胞频率增加。
  • 诊断时及难治患者T细胞耗竭标志物表达升高,包括调节性T细胞。
  • 诊断时血浆TNF-α和IL-6水平显著升高,提示促炎状态。

核心结论

  • CML诊断时存在T细胞耗竭和促炎状态,可能继发于白血病相关抗原负荷增加。

研究设计与样本

  • 研究类型原文未明确报告,样本量原文未报告。

主要发现

  • 诊断时调节性T细胞和效应调节性T细胞频率增加。
  • 诊断时及难治患者T细胞耗竭标志物表达增加,包括调节性T细胞。
  • 血浆TNF-α和IL-6水平在诊断时显著升高。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The search for novel targets in chronic myeloid leukaemia (CML) is ongoing, to improve treatment efficacy in refractory disease and increase eligibility for tyrosine kinase inhibitor (TKI) discontinuation. Increased frequency of Tregs and effector Tregs was evident at diagnosis, together with increased expression of T-cell exhaustion markers, including in regulatory T cells at diagnosis and in patients with refractory disease. Plasma analysis revealed significantly increased levels of cytokines including tumour necrosis factor (TNF)-a and interleukin (IL)-6 at diagnosis, in keeping with a pro-inflammatory state prior to treatment. We hence demonstrate T-cell exhaustion and a pro-inflammatory state at diagnosis in CML, likely secondary to leukaemia-associated antigenic overload associated with increased disease burden.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Harrington P, Dillon R, Radia D, et al. Chronic myeloid leukaemia patients at diagnosis and resistant to tyrosine kinase inhibitor therapy display exhausted T-cell phenotype. Br J Haematol. 2022. PMID: 35802024. doi:10.1111/bjh.18302

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。